• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

国立神经疾病与中风研究所帕金森病长期研究-1中1736名参与者的认知功能。

Cognitive function in 1736 participants in NINDS Exploratory Trials in PD Long-term Study-1.

作者信息

Wills Anne-Marie A, Elm Jordan J, Ye Rong, Chou Kelvin L, Parashos Sotirios A, Hauser Robert A, Bodis-Wollner Ivan, Hinson Vanessa K, Christine Chadwick W, Schneider Jay S

机构信息

Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.

Medical University of South Carolina, Division of Biostatistics & Epidemiology, Charleston, SC, USA.

出版信息

Parkinsonism Relat Disord. 2016 Dec;33:127-133. doi: 10.1016/j.parkreldis.2016.10.005. Epub 2016 Oct 8.

DOI:10.1016/j.parkreldis.2016.10.005
PMID:27743701
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6091572/
Abstract

INTRODUCTION

Clinical cohort studies suggest that mild cognitive impairment (MCI) is common in early Parkinson's disease (PD). The objectives of this paper were to describe cognitive function in a large clinical trial of early treated PD patients at baseline and over time using two brief cognitive screening tests.

METHODS

In total 1741 participants were enrolled in the NINDS Exploratory Trials in Parkinson's disease (NET-PD) Long-term Study-1 (LS-1). The Symbol Digit Modalities Test (SDMT) was collected annually. The SCales for Outcomes in PArkinson's disease-COGnition (SCOPA-COG) was collected at baseline and at year 5. The trial was stopped early based on a planned interim analysis after half the cohort completed 5 years of follow-up. The median length of follow-up was 4 years (range 3-6 years). Predictors of cognitive change were examined using cross sectional (baseline) and longitudinal multivariable linear regression.

RESULTS

The mean (SD) change from baseline to 5 years was -1.9 (5.1) for the SCOPA-COG and -2.1 (11.1) for the SDMT. Age and baseline UPDRS motor scores were associated with a more rapid decline in SDMT scores and 5 year SCOPA-COG scores. Male gender was associated with more rapid decline in SDMT. Self-reported income was a novel predictor of baseline cognitive function, even adjusted for educational status, although not significantly associated with change over time.

CONCLUSION

This large prospective cohort study demonstrated mild cognitive decline in early treated Parkinson's disease. The study identified income level as a novel predictor of cognitive function.

摘要

引言

临床队列研究表明,轻度认知障碍(MCI)在早期帕金森病(PD)中很常见。本文的目的是使用两项简短的认知筛查测试,描述早期接受治疗的PD患者在一项大型临床试验中的基线认知功能以及随时间的变化情况。

方法

共有1741名参与者纳入了国立神经疾病和中风研究所帕金森病探索性试验(NET-PD)长期研究-1(LS-1)。每年收集符号数字模式测试(SDMT)结果。在基线和第5年收集帕金森病认知功能结局量表(SCOPA-COG)。在队列的一半完成5年随访后,根据计划的中期分析提前终止了试验。随访的中位时长为4年(范围3 - 6年)。使用横断面(基线)和纵向多变量线性回归分析认知变化的预测因素。

结果

SCOPA-COG从基线到5年的平均(标准差)变化为-1.9(5.1),SDMT为-2.1(11.1)。年龄和基线统一帕金森病评定量表(UPDRS)运动评分与SDMT评分和5年SCOPA-COG评分的更快下降相关。男性与SDMT评分的更快下降相关。自我报告的收入是基线认知功能的一个新的预测因素,即使在调整了教育程度后也是如此,尽管与随时间的变化无显著关联。

结论

这项大型前瞻性队列研究表明,早期接受治疗的帕金森病存在轻度认知下降。该研究确定收入水平是认知功能的一个新的预测因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3634/6091572/304a4c1004fe/nihms978004f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3634/6091572/1dcd93460b22/nihms978004f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3634/6091572/304a4c1004fe/nihms978004f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3634/6091572/1dcd93460b22/nihms978004f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3634/6091572/304a4c1004fe/nihms978004f2.jpg

相似文献

1
Cognitive function in 1736 participants in NINDS Exploratory Trials in PD Long-term Study-1.国立神经疾病与中风研究所帕金森病长期研究-1中1736名参与者的认知功能。
Parkinsonism Relat Disord. 2016 Dec;33:127-133. doi: 10.1016/j.parkreldis.2016.10.005. Epub 2016 Oct 8.
2
Responsiveness to Change of the Montreal Cognitive Assessment, Mini-Mental State Examination, and SCOPA-Cog in Non-Demented Patients with Parkinson's Disease.蒙特利尔认知评估量表、简易精神状态检查和 SCOPA-Cog 在非痴呆帕金森病患者中的变化反应性。
Dement Geriatr Cogn Disord. 2019;47(4-6):187-197. doi: 10.1159/000496454. Epub 2019 Jul 17.
3
Addenbrooke's Cognitive Examination validation in Parkinson's disease.阿登布鲁克认知测验在帕金森病中的验证。
Eur J Neurol. 2009 Jan;16(1):142-7. doi: 10.1111/j.1468-1331.2008.02384.x. Epub 2008 Nov 25.
4
Clinical predictors of cognitive impairment and psychiatric complications in Parkinson's disease.帕金森病认知障碍和精神并发症的临床预测因素
Arq Neuropsiquiatr. 2015 May;73(5):390-5. doi: 10.1590/0004-282X20150016.
5
Extended "Timed Up and Go" assessment as a clinical indicator of cognitive state in Parkinson's disease.扩展版“起立行走测试”作为帕金森病认知状态的临床指标
J Neurol Sci. 2017 Apr 15;375:86-91. doi: 10.1016/j.jns.2017.01.050. Epub 2017 Jan 17.
6
Association Between Change in Body Mass Index, Unified Parkinson's Disease Rating Scale Scores, and Survival Among Persons With Parkinson Disease: Secondary Analysis of Longitudinal Data From NINDS Exploratory Trials in Parkinson Disease Long-term Study 1.帕金森病患者体重指数变化、统一帕金森病评定量表评分与生存率之间的关联:国立神经疾病和中风研究所帕金森病长期研究1探索性试验纵向数据的二次分析
JAMA Neurol. 2016 Mar;73(3):321-8. doi: 10.1001/jamaneurol.2015.4265.
7
Diagnosis of possible mild cognitive impairment in Parkinson's disease: validity of the SCOPA-Cog.帕金森病可能轻度认知障碍的诊断:SCOPA-Cog 的有效性。
Parkinsonism Relat Disord. 2013 Dec;19(12):1160-3. doi: 10.1016/j.parkreldis.2013.08.008. Epub 2013 Aug 22.
8
Cognitive impairment in early-stage non-demented Parkinson's disease patients.早期非痴呆帕金森病患者的认知障碍。
Acta Neurol Scand. 2014 May;129(5):307-18. doi: 10.1111/ane.12189. Epub 2013 Oct 11.
9
Predictors of weight loss in early treated Parkinson's disease from the NET-PD LS-1 cohort.帕金森病早期治疗中体重减轻的预测因素:来自NET-PD LS-1队列研究
J Neurol. 2017 Aug;264(8):1746-1753. doi: 10.1007/s00415-017-8562-4. Epub 2017 Jul 15.
10
Predictors of Functional Decline in Early Parkinson's Disease: NET-PD LS1 Cohort.早期帕金森病功能衰退的预测因素:NET-PD LS1 队列。
J Parkinsons Dis. 2015;5(4):773-82. doi: 10.3233/JPD-150668.

引用本文的文献

1
Improvements in clinical signs and symptoms of Parkinson's disease using photobiomodulation: a five-year follow-up.应用光生物调节改善帕金森病的临床症状和体征:五年随访。
BMC Neurol. 2024 Oct 9;24(1):381. doi: 10.1186/s12883-024-03857-z.
2
Assessment tools for cognitive performance in Parkinson's disease and its genetic contributors.帕金森病认知功能及其遗传因素的评估工具。
Front Neurol. 2024 Jun 26;15:1413187. doi: 10.3389/fneur.2024.1413187. eCollection 2024.
3
Time-course of decline in different cognitive domains in Parkinson's disease: a retrospective study.

本文引用的文献

1
Rasagiline for mild cognitive impairment in Parkinson's disease: A placebo-controlled trial.雷沙吉兰用于帕金森病轻度认知障碍:一项安慰剂对照试验。
Mov Disord. 2016 May;31(5):709-14. doi: 10.1002/mds.26617. Epub 2016 Mar 31.
2
The influence of age and approaching death on the course of nondopaminergic symptoms in Parkinson's disease.年龄和临近死亡对帕金森病非多巴胺能症状病程的影响。
Parkinsonism Relat Disord. 2016 Mar;24:113-8. doi: 10.1016/j.parkreldis.2015.12.007. Epub 2015 Dec 15.
3
Cognition in individuals at risk for Parkinson's: Parkinson associated risk syndrome (PARS) study findings.
帕金森病不同认知领域衰退的时间进程:一项回顾性研究。
J Neural Transm (Vienna). 2022 Sep;129(9):1179-1187. doi: 10.1007/s00702-021-02441-w. Epub 2021 Nov 24.
4
Olfaction and taste in Parkinson's disease: the association with mild cognitive impairment and the single cognitive domain dysfunction.帕金森病的嗅觉和味觉:与轻度认知障碍和单一认知领域功能障碍的关联。
J Neural Transm (Vienna). 2019 May;126(5):585-595. doi: 10.1007/s00702-019-01996-z. Epub 2019 Mar 25.
5
An increased rate of longitudinal cognitive decline is observed in Parkinson's disease patients with low CSF Aß42 and an APOE ε4 allele.在伴有低 CSF Aβ42 和 APOE ε4 等位基因的帕金森病患者中,观察到纵向认知衰退率增加。
Neurobiol Dis. 2019 Jul;127:278-286. doi: 10.1016/j.nbd.2019.02.023. Epub 2019 Feb 28.
6
Progression of Cognitive Decline in Parkinson's Disease.帕金森病认知衰退的进展。
J Parkinsons Dis. 2018;8(2):183-193. doi: 10.3233/JPD-181306.
7
Association of metabolic syndrome and change in Unified Parkinson's Disease Rating Scale scores.代谢综合征与统一帕金森病评定量表评分变化的关联
Neurology. 2017 Oct 24;89(17):1789-1794. doi: 10.1212/WNL.0000000000004572. Epub 2017 Sep 29.
8
Diagnosing mild cognitive impairment in Parkinson's disease: which tests perform best in the Italian population?帕金森病轻度认知障碍的诊断:哪些测试在意大利人群中表现最佳?
Neurol Sci. 2017 Aug;38(8):1461-1468. doi: 10.1007/s10072-017-3000-z. Epub 2017 May 26.
帕金森病高危个体的认知:帕金森相关风险综合征(PARS)研究结果。
Mov Disord. 2016 Jan;31(1):86-94. doi: 10.1002/mds.26373. Epub 2015 Aug 21.
4
Effect of creatine monohydrate on clinical progression in patients with Parkinson disease: a randomized clinical trial.一水肌酸对帕金森病患者临床进展的影响:一项随机临床试验。
JAMA. 2015 Feb 10;313(6):584-93. doi: 10.1001/jama.2015.120.
5
The Symbol Digit Modalities Test: Normative data from a large nationally representative sample of Australians.符号数字模态测验:来自具有全国代表性的澳大利亚大样本的常模数据。
Arch Clin Neuropsychol. 2014 Dec;29(8):767-75. doi: 10.1093/arclin/acu055. Epub 2014 Oct 28.
6
Predictors of dementia in Parkinson disease: a prospective cohort study.帕金森病痴呆的预测因素:一项前瞻性队列研究。
Neurology. 2014 Sep 30;83(14):1253-60. doi: 10.1212/WNL.0000000000000842. Epub 2014 Aug 29.
7
Predictors of dementia in Parkinson's disease; findings from a 5-year prospective study using the SCOPA-COG.帕金森病痴呆的预测因素;一项使用SCOPA-COG的5年前瞻性研究的结果
Parkinsonism Relat Disord. 2014 Sep;20(9):980-5. doi: 10.1016/j.parkreldis.2014.06.006. Epub 2014 Jun 26.
8
Diagnosis of possible mild cognitive impairment in Parkinson's disease: validity of the SCOPA-Cog.帕金森病可能轻度认知障碍的诊断:SCOPA-Cog 的有效性。
Parkinsonism Relat Disord. 2013 Dec;19(12):1160-3. doi: 10.1016/j.parkreldis.2013.08.008. Epub 2013 Aug 22.
9
Measuring mild cognitive impairment in patients with Parkinson's disease.测量帕金森病患者的轻度认知障碍。
Mov Disord. 2013 May;28(5):626-33. doi: 10.1002/mds.25426. Epub 2013 Mar 20.
10
SCOPA-cognition cutoff value for detection of Parkinson's disease dementia.SCOPA-cognition 认知筛查截断值用于帕金森病痴呆的检测。
Mov Disord. 2011 Aug 15;26(10):1881-6. doi: 10.1002/mds.23750. Epub 2011 May 3.